Navigation Links
Researchers Use Gene Therapy to Restore Eyesight in Blind Mice

A new study has used gene therapy to bring back eyesight in mice that had a form of hereditary blindness.

The finding may have an impact on many of the common blinding diseases in humans, researchers now state.

The study was conducted by a team of researchers led by John J. Alexander at the University of Florida.

As part of the study, researchers conducted experiments on mice that had a hereditary blindness called achromatopsia.

This disease affects eyesight by putting cone photoreceptors in the retina out of action. The disease not only causes almost complete color blindness, but also very poor central vision.

As a part of the research the researchers used a harmless virus to provide corrective genes to mice with a genetic impairment that blocks their vision.

Researchers measured the electrical activity in the retinas of mice for two months after the administering the gene therapy injection into the subretinal space of the rodents.

Scientists found that 19 out of the 21 treated eyes responded to therapy positively, and 17 of those 19 had electrical readings from their retinas much similar to those taken in normal mice.

Tests in mice between 6 and 7 months old showed that 18 of the 21 treated eyes responded in a normal manner.

Also, a smaller group of treated mice were assessed with a test similar to doctors eye test. Researchers found that the mice had normal visual perception with their treated eyes.

"People can talk and tell us what they see," Nature quoted Alexander, as saying.

"Animals are much more difficult. What makes this test so fantastic is that it involves an animals natural response, and the results tell us that the animals brains are involved in the process, that they are actually seeing something," he added.

The research shows that it is possible to focus and save cone cells which are th e vital for visual sharpness and color vision in people.

According to Richard Weleber, a professor of molecular and medical genetics at Oregon Health & Science University who was not involved in the research, the study this cone-targeted gene therapy is first on its kind and has great implications for a number of degenerative diseases.

"This is the first to my knowledge of a cone-targeted gene therapy that restores function in an animal model where cones are the primary defect," Weleber said.

"This validates the concept that it is possible to deliver a gene therapy targeting the cone system, and that is incredibly important for a number of degenerative diseases," he added.

The findings of the study were published in the online edition of Nature Medicine.


'"/>




Related medicine news :

1. Researchers urge caution in using ear tube surgery
2. Researchers Scale to assess the Severity of Epilepsy in Kids
3. Researchers trick Alzheimers Enzyme
4. Researchers find new HIV hiding place
5. New Hair in 15 Days Could Now Be A Possibility Say Researchers
6. Researchers developed world’s smallest toothbrus
7. Researchers discover receptor cells that can cause epilepsy
8. 15 Anti-SARS Drugs Identified By China-Europe Team of Researchers
9. Researchers reversed the process of memory loss
10. Researchers Identify Key Gene That May Help Brain Treatment
11. Researchers Discover Protein That Causes Malaria
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... June 25, 2016 , ... Experts from ... at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center ... care topics including advance care planning, healthcare costs and patient and family engagement. ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from PsychTests.com reveals that behind ...
(Date:6/24/2016)... ... ... a crisis. Her son James, eight, was out of control. Prone to extreme mood shifts ... upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife ... and say he was going to kill them. If we were driving on the ...
(Date:6/24/2016)... ... 2016 , ... Comfort Keepers® of San Diego, CA is excited to announce ... program to drive cancer patients to and from their cancer treatments. Comfort Keepers ... of life and ongoing independence. Getting to and from medical treatments is one ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
(Date:6/23/2016)... 2016  MedSource announced today that it has ... solution of choice.  This latest decision demonstrates MedSource,s ... their clients by offering a state-of-the-art electronic data ... nowEDC as the EDC platform of choice in ... "nowEDC has long been a preferred EDC platform ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
Breaking Medicine Technology: